United States · Biotechnology
Research
Pharmaceuticals
Biotechnology
Xellarbio is at the forefront of drug discovery innovation with its organ-on-chip platform. This cutting-edge technology utilizes pharmaceutical-scale engineering and advanced AI to create physiologically realistic human organ models. By addressing limitations of current drug discovery methods, Xellarbio's platform enables higher predictive accuracy, cost-effective high-throughput screening, and superior risk assessment, all while significantly reducing reliance on animal testing.
2025
Founded
Biotechnology
Industry
United States
Location
590,525,791
Ranking
0 employees
Size
Get full access to view complete information
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© Pubrio 2026
